98 related articles for article (PubMed ID: 8875442)
21. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
22. Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP.
Bredow S; Kacsóh B; Obál F; Fang J; Krueger JM
Brain Res; 1994 Oct; 660(2):301-8. PubMed ID: 7820699
[TBL] [Abstract][Full Text] [Related]
23. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
[TBL] [Abstract][Full Text] [Related]
24. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
25. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
[TBL] [Abstract][Full Text] [Related]
26. Effect of pituitary adenylate cyclase activating polypeptide on rat pancreatic exocrine secretion.
Mungan Z; Ertan A; Hammer RA; Arimura A
Peptides; 1991; 12(3):559-62. PubMed ID: 1717954
[TBL] [Abstract][Full Text] [Related]
27. Contrasting effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vivo and in vitro prolactin and growth hormone release in male rats.
Jarry H; Leonhardt S; Schmidt WE; Creutzfeldt W; Wuttke W
Life Sci; 1992; 51(11):823-30. PubMed ID: 1522745
[TBL] [Abstract][Full Text] [Related]
28. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of action of pituitary adenylate cyclase-activating polypeptide on human glycoprotein hormone alpha-subunit transcription in alphaT3-1 gonadotropes.
Burrin JM; Aylwin SJ; Holdstock JG; Sahye U
Endocrinology; 1998 Apr; 139(4):1731-7. PubMed ID: 9528956
[TBL] [Abstract][Full Text] [Related]
30. Pituitary folliculo-stellate-like cell line (TtT/GF) responds to novel hypophysiotropic peptide (pituitary adenylate cyclase-activating peptide), showing increased adenosine 3',5'-monophosphate and interleukin-6 secretion and cell proliferation.
Matsumoto H; Koyama C; Sawada T; Koike K; Hirota K; Miyake A; Arimura A; Inoue K
Endocrinology; 1993 Nov; 133(5):2150-5. PubMed ID: 8404665
[TBL] [Abstract][Full Text] [Related]
31. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
[TBL] [Abstract][Full Text] [Related]
32. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
[TBL] [Abstract][Full Text] [Related]
33. Effects of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide, and somatostatin on the release of thyrotropin from the bullfrog pituitary.
Okada R; Yamamoto K; Ito Y; Chartrel N; Leprince J; Fournier A; Vaudry H; Kikuyama S
Ann N Y Acad Sci; 2006 Jul; 1070():474-80. PubMed ID: 16888212
[TBL] [Abstract][Full Text] [Related]
34. Comparison between the effects of VIP and the novel peptide PACAP on the exocrine pancreatic secretion of the rat.
Alonso RM; Rodríguez AM; García LJ; López MA; Calvo JJ
Pancreas; 1994 Jan; 9(1):123-8. PubMed ID: 7509062
[TBL] [Abstract][Full Text] [Related]
35. Possible involvement of vasoactive intestinal polypeptide in the central stimulating action of pituitary adenylate cyclase-activating polypeptide on prolactin secretion in the rat.
Yamauchi K; Murakami Y; Nishiki M; Tanaka J; Koshimura K; Kato Y
Neurosci Lett; 1995 Apr; 189(2):131-4. PubMed ID: 7609919
[TBL] [Abstract][Full Text] [Related]
36. Effect of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on mouse preantral follicle development in vitro.
Cecconi S; Rossi G; Barberi M; Scaldaferri L; Canipari R
Endocrinology; 2004 Apr; 145(4):2071-9. PubMed ID: 14701671
[TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal peptide, but not pituitary adenylate cyclase-activating peptide, modulates the responsiveness of the gonadotroph to LHRH in man.
Hammond PJ; Talbot K; Chapman R; Ghatei MA; Bloom SR
J Endocrinol; 1993 Jun; 137(3):529-32. PubMed ID: 8371083
[TBL] [Abstract][Full Text] [Related]
38. Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion.
Lutz-Bucher B; Monnier D; Koch B
Neuroendocrinology; 1996 Aug; 64(2):153-61. PubMed ID: 8857610
[TBL] [Abstract][Full Text] [Related]
39. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
40. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
